Literature DB >> 21549125

Preclinical studies of human disease: time to take methodological quality seriously.

H Bart van der Worp, Malcolm R Macleod.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21549125     DOI： 10.1016/j.yjmcc.2011.04.008

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN： 0022-2828            Impact factor:   5.000


× No keyword cloud information.
  27 in total

1.  Novel therapies, high-risk pediatric research, and the prospect of benefit: learning from the ethical disagreements.

Authors:  Inmaculada de Melo-Martín; Dolan Sondhi; Ronald G Crystal
Journal:  Mol Ther       Date:  2012-06       Impact factor: 11.454

2.  Human in vitro models of ischaemic stroke: a test bed for translation.

Authors:  Ana Antonic; Emily S Sena; Geoffrey A Donnan; David W Howells
Journal:  Transl Stroke Res       Date:  2012-07-21       Impact factor: 6.829

3.  Preclinical progenitor cell therapy in traumatic brain injury: a meta-analysis.

Authors:  Margaret L Jackson; Amit K Srivastava; Charles S Cox
Journal:  J Surg Res       Date:  2017-03-08       Impact factor: 2.192

Review 4.  New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs.

Authors:  Salvatore Salomone; Filippo Caraci; Gian Marco Leggio; Julia Fedotova; Filippo Drago
Journal:  Br J Clin Pharmacol       Date:  2012-04       Impact factor: 4.335

Review 5.  Application of the Navigation Guide systematic review methodology to the evidence for developmental and reproductive toxicity of triclosan.

Authors:  Paula I Johnson; Erica Koustas; Hanna M Vesterinen; Patrice Sutton; Dylan S Atchley; Allegra N Kim; Marlissa Campbell; James M Donald; Saunak Sen; Lisa Bero; Lauren Zeise; Tracey J Woodruff
Journal:  Environ Int       Date:  2016-05-05       Impact factor: 9.621

6.  Reproducibility and transparency in biomedical sciences.

Authors:  G Gannot; M A Cutting; D J Fischer; L J Hsu
Journal:  Oral Dis       Date:  2016-11-24       Impact factor: 3.511

7.  A call for transparent reporting to optimize the predictive value of preclinical research.

Authors:  Story C Landis; Susan G Amara; Khusru Asadullah; Chris P Austin; Robi Blumenstein; Eileen W Bradley; Ronald G Crystal; Robert B Darnell; Robert J Ferrante; Howard Fillit; Robert Finkelstein; Marc Fisher; Howard E Gendelman; Robert M Golub; John L Goudreau; Robert A Gross; Amelie K Gubitz; Sharon E Hesterlee; David W Howells; John Huguenard; Katrina Kelner; Walter Koroshetz; Dimitri Krainc; Stanley E Lazic; Michael S Levine; Malcolm R Macleod; John M McCall; Richard T Moxley; Kalyani Narasimhan; Linda J Noble; Steve Perrin; John D Porter; Oswald Steward; Ellis Unger; Ursula Utz; Shai D Silberberg
Journal:  Nature       Date:  2012-10-11       Impact factor: 49.962

8.  Look back in anger - what clinical studies tell us about preclinical work.

Authors:  Thomas Hartung
Journal:  ALTEX       Date:  2013       Impact factor: 6.043

9.  Therapies to limit myocardial injury in animal models of myocarditis: a systematic review and meta-analysis.

Authors:  Joshua A Silverblatt; Oliver J Ziff; Luke Dancy; Allen Daniel; Ben Carter; Paul Scott; Daniel M Sado; Ajay Shah; Daniel I Bromage
Journal:  Basic Res Cardiol       Date:  2019-10-31       Impact factor: 17.165

10.  Systematic Review and Methodological Considerations for the Use of Single Prolonged Stress and Fear Extinction Retention in Rodents.

Authors:  Chantelle Ferland-Beckham; Lauren E Chaby; Nikolaos P Daskalakis; Dayan Knox; Israel Liberzon; Miranda M Lim; Christa McIntyre; Shane A Perrine; Victoria B Risbrough; Esther L Sabban; Andreas Jeromin; Magali Haas
Journal:  Front Behav Neurosci       Date:  2021-05-14       Impact factor: 3.558
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.